Sandoz's approval of Afqlir highlights their commitment to affordable, effective treatment options for retinal diseases.

Ophthalmologists use optical coherence tomography (OCT) to assess whether a patient with age-related macular degeneration (AMD) requires treatment at their scheduled appointment or can wait a few more ...

Sandoz receives European Commission approval for Afqlir® (aflibercept), further strengthening leading biosimilar portfolio.

Sponsored content Eye health is something many of us take for granted. But looking after our eyes is important for ...

Ms. Connell is a commercial executive with business development expertiseAppointment takes place as Opthea prepares for Phase 3 wet AMD topline ...

MEDIA RELEASEAfqlir® (aflibercept) approved to treat various retinal diseases, including neovascular age-related macular degeneration (nAMD)One ...

HealthDay News — Socioeconomic factors are linked to an increased risk for age-related macular degeneration (AMD), according to a study published online July 1 in Health Data Science.

SOL-1 expected to be fully randomized by YE 2024 with topline data expected in Q4 2025 Cash balance of $427.2M as of September 30, 2024, expected to fund operations into 2028 Ocular to host a Q3 2024 ...

SUMMARY: Notice is hereby given that the Department of Veterans Affairs (VA), Office of Research and Development, Technology ...

Neuralink Corp., Elon Musk’s brain-computer venture, and rivals like Science Corp. are making strides in technology that ...

Researchers at Johns Hopkins University have identified a process in the eye that may explain why biologic drugs for treating ...